Equities analysts expect that Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT – Get Rating) will post earnings of ($0.75) per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Opiant Pharmaceuticals’ earnings, with the highest EPS estimate coming in at ($0.20) and the lowest estimate coming in at ($1.22). Opiant Pharmaceuticals reported earnings per share of ($0.66) in the same quarter last year, which would suggest a negative year over year growth rate of 13.